[Acquired tufted angioma in an adult: failure of pulsed dye laser therapy].

Ann Dermatol Venereol

Service de Dermatologie, CHU Trousseau, Tours.

Published: January 1998

AI Article Synopsis

Article Abstract

Background: Tufted angioma, described by Wilson Jones in 1976, is a benign acquired vascular tumor occurring in children or young adults, usually located on the neck or the upper part of the thorax. Pathology examination confirms the diagnosis showing well-limited lobules in the dermis composed of tight clusters of capillaries without atypical cells.

Case Report: An 81-year-old woman consulted for a large extensive angiomatous lesion involving the neck and shoulder which had developed over two years. Histopathology reported tufted angioma. Treatment with pulsed dye laser was unsuccessful.

Discussion: Different treatments have been proposed for tufted angiomas: surgery, cryotherapy, interferon, argon laser and pulsed dye laser. This is a second cases of unsuccessful treatment, perhaps due to deep extension of the angioma.

Download full-text PDF

Source

Publication Analysis

Top Keywords

tufted angioma
12
pulsed dye
12
dye laser
12
[acquired tufted
4
angioma
4
angioma adult
4
adult failure
4
failure pulsed
4
laser
4
laser therapy]
4

Similar Publications

Acquired tufted angioma with perinatal progression and complete spontaneous regression post-delivery: a case report and literature review on the expression of sex hormone receptors.

Eur J Dermatol

June 2024

Department of Dermatology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8677 Japan, Department of Dermatology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670 Japan.

View Article and Find Full Text PDF

Anticoagulation and vascular anomalies.

Res Pract Thromb Haemost

March 2024

Division of Pediatric Hematology-Oncology, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas, USA.

Article Synopsis
  • A lecture titled "Anticoagulation and Vascular Anomalies" was held at the ISTH Congress in 2023, discussing the management of vascular anomalies which are categorized as tumors or malformations.
  • Some vascular tumors and malformations may lead to coagulation issues, but anticoagulation is generally not the standard treatment for these conditions, except for specific cases.
  • Slow-flow vascular malformations carry a higher risk of venous thromboembolism (VTE), and in these cases, anticoagulation may be necessary to mitigate risks and manage symptoms, with new data on these subjects presented at the conference.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!